Literature DB >> 4560340

Cellular immunity to nuclear antigens in systemic lupus erythematosus.

J A Goldman, A Litwin, L E Adams, R C Krueger, E V Hess.   

Abstract

Cellular immune repsonses were determined by skin testing and mitogen- and antigen-induced blastic transformation of peripheral blood lymphocyte cultures in 24 patients with systemic lupus erythematosus (SLE) and 24 normal subjects. The incidence of positive skin tests with Candida albicans, PPD (tuberculin-purified protein derivative) intermediate strength, Trichophyton and histoplasmin was not significantly different in the two groups nor was lymphocyte stimulation by the mitogen phytohemagglutinin-M (PHA-M), implying that cellular immunity is normal in SLE. However, the SLE patients had a significantly increased incidence of positive skin tests and stimulated lymphocyte cultures to a number of nuclear antigens compared with normal subjects. No correlation could be made between the test results and the activity of the SLE at the time of study except for a significant association between lymphocyte culture stimulation by rabbit thymus native DNA and active SLE nephritis. Patients with a membranous antinuclear factor (ANF) pattern had positive skin tests with rabbit thymus native DNA and usually had active disease.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4560340      PMCID: PMC332966          DOI: 10.1172/JCI107085

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  The immunologic significance of antigen induced lymphocyte transformation in vitro.

Authors:  J A Mills
Journal:  J Immunol       Date:  1966-08       Impact factor: 5.422

2.  Antinuclear antibodies in mice. II. Transmission with spleen cells; inhibition or prevention with thymus or spleen cells.

Authors:  P O Teague; G J Friou
Journal:  Immunology       Date:  1969-11       Impact factor: 7.397

3.  Intradermal tests and antinuclear factors in systemic lupus erythematosus. A comparative study.

Authors:  F J Azoury; H E Jones; V J Derbes; O B Gum
Journal:  Ann Intern Med       Date:  1966-12       Impact factor: 25.391

4.  The specificity of antigen-induced thymidine-2-14C incorporation into lymph node cells frrom sensitized animals.

Authors:  M Stulbarg; S F Schlossman
Journal:  J Immunol       Date:  1968-10       Impact factor: 5.422

5.  A new type of deoxyribonucleoprotein isolated from rabbit thymus nuclei.

Authors:  A W Rees; R C Krueger
Journal:  Biochim Biophys Acta       Date:  1968-07-23

6.  Delayed hypersensitivity in systemic lupus erythematosus.

Authors:  S R Block; C B Gibbs; M B Stevens; L E Shulman
Journal:  Ann Rheum Dis       Date:  1968-07       Impact factor: 19.103

7.  The response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA.

Authors:  A Patrucco; N F Rothfield; K Hirschhorn
Journal:  Arthritis Rheum       Date:  1967-02

8.  Skin tests with nuclear factors in systemic lupus erythematosus.

Authors:  H E Jones; V J Derbes; O B Gum; F J Azoury
Journal:  Arch Dermatol       Date:  1967-06

9.  Delayed hypersensitivity in the guinea-pig to a protein-hapten conjugate and its relationship to in vitro transformation of lymph node, spleen, thymus and peripheral blood lymphocytes.

Authors:  J J Oppenheim; R A Wolstencroft; P G Gell
Journal:  Immunology       Date:  1967-01       Impact factor: 7.397

10.  Role of the thymus in tolerance. 3. Tolerance to bovine gamma globulin after direct injection of antigen into the shielded thymus of irradiated rats.

Authors:  P J Staples; I Gery; B H Waksman
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  10 in total

1.  Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

Authors:  D A Horwitz; M A Garrett
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

2.  Cell-mediated immunity in systemic lupus erythematosus.

Authors:  A A Andrianakos; P N Tsichlis; E G Merikas; S G Marketos; J T Sharp; G E Merikas
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

3.  Peripheral blood lymphocyte response to phytomitogens in systemic lupus erythematosus.

Authors:  B Foad; L E Adams; A Litwin; E V Hess
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

4.  Study of lymphocyte subpopulations in normal humans and patients with systemic lupus erythematosus by fractionation of peripheral blood lymphocytes on a discontinuous Ficoll gradient.

Authors:  W Glinski; M E Gershwin; D R Budman; A D Steinberg
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

5.  Cellular immunity in systemic lupus erythematosus as evidenced in vitro by leucocyte migration inhibition tests.

Authors:  M Okubo; Y Nagura; D Pompa; G Treser; K Lange
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

6.  Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus.

Authors:  B Charpentier; C Carnaud; J F Bach
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

7.  The production of a "universal developer" for the immunological detection of human IgG and its application in immunodiagnostics.

Authors:  F M Semenenko; R L Kenigsberg; A C Cuello
Journal:  Histochemistry       Date:  1988

8.  Immunopathologic studies in relapsing polychondritis.

Authors:  J H Herman; M V Dennis
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

9.  In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus.

Authors:  C Morimoto; A D Steinberg; S F Schlossman; Y Borel
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  Cytotoxic responses to alloantigens in systemic lupus erythematosus.

Authors:  G C Tsokos; J E Balow
Journal:  J Clin Immunol       Date:  1981-10       Impact factor: 8.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.